SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-21-000059
Filing Date
2021-06-22
Accepted
2021-06-22 16:44:19
Documents
1
Period of Report
2021-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162439463312605.html 4  
1 FORM 4 wf-form4_162439463312605.xml 4 11278
  Complete submission text file 0001439222-21-000059.txt   12702
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 38 SIDNEY STREET, 2ND FLOOR CAMBRIDGE MA 02139
Business Address
Bowden Christopher (Reporting) CIK: 0001608601 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 211035896